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Purpose of the study 
A previous screening programme, GADIS I, revealed important regional differences in the 
prevalence of GAD and MDD in Belgium. This study is aimed to determine if socio-economic 
factors such as relationship, education, employment can explain differences in the prevalence of 
GAD and MDD in Primary Care and if they impair the patient's functioning. 
Method used 
377 General Practitioners were asked to participate in a large scale screening programme. 
Between September 2002 and March 2003, each physician screened 40 consecutive patients at 
predefined time periods. After informed consent, all questions from the GAD and MDD sections 
of the Mini International Neuropsychiatric Interview (MINI) were completed. Current treatment 
was documented and socio-economic parameters collected. Impact on the patient's functioning 
was assessed using the Sheehan Disability Scale. Results are expressed as means ± standard 
deviations (SDs) for quantitative variables and as counts and proportions (prevalences) for 
categorical findings. Statistical analyses were always can1ed out on the maximum number of 
data available using the SAS (version 8.02 for Windows) and S-Plus (version 6.1) software 
packages. 
Results 
A total of 13.699 patients were screened. There were 60% of women and 40% men with a mean 
age of 49.3±17 years. DSM-IV defined GAD alone was diagnosed in 6.8%, depression alone in 
4.4% and comorbidity of depression and generalised anxiety in 6.6%. Overall, 17.8% of the 
patients were diagnosed with GAD or MDD. A new diagnosis was made in 71.4% of these cases, 
54.2% were already treated for anxiety and 44.0% for depression. The scores on the Sheehan 
Disability Scale showed significant disability on work, social and family life in positive patients. 
Comorbidity results in the highest levels of impairment with mean score of 7±2 as compared to 
2±2 in negative patients. Higher prevalence of GAD and MDD is found in Brussels (18.8% and 
15.4%) and Wallonia (16.7% and 14.2%) compared to Flanders (9.8% and 7.7%). GAD and MDD 
are most correlated with gender, region, relationship and employement. No association was 
found with education. 
Conclusion 
This large scale epidemiological study shows that GAD and MDD are highly prevalent in primary 
care and frequently comorbid. They result in important impairment in professional, social and 
family functioning. Some Socio-economic factors play an important role in prevalence of GAD 
and MDD. 
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